(NYSE: NGVT) Ingevity's forecast annual revenue growth rate of -4.02% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 3.06%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.63%.
Ingevity's revenue in 2024 is $1,692,100,000.On average, 3 Wall Street analysts forecast NGVT's revenue for 2024 to be $53,190,655,592, with the lowest NGVT revenue forecast at $51,636,136,125, and the highest NGVT revenue forecast at $55,346,690,749. On average, 3 Wall Street analysts forecast NGVT's revenue for 2025 to be $56,854,103,565, with the lowest NGVT revenue forecast at $54,824,894,005, and the highest NGVT revenue forecast at $60,350,866,468.
In 2026, NGVT is forecast to generate $59,028,256,665 in revenue, with the lowest revenue forecast at $59,028,256,665 and the highest revenue forecast at $59,028,256,665.